News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
A year of discovery: Looking back at 2025 and ahead to 2026
In 2025, RECOVER’s progress included closing the first phase of its adult observational study and publishing its first clinical trial results. This year, the initiative continues its studies and sharing research findings.
Feature
147 Results
147 Results
Food insecurity and adverse social conditions tied to increased risk of Long COVID in children
In a study published in JAMA Pediatrics, RECOVER researchers analyzed data from over 4,500 school-aged children and adolescents to understand the relationship between social risk factors and the risk for developing Long COVID.
Announcement
RECOVER-TLC to hold next webinar January 23, 2026
On January 23, NIH and FNIH leaders will hold a RECOVER-TLC webinar to provide updates and answer questions about RECOVER’s latest clinical trial efforts.
Announcement
R3 Seminar Recap: Using RECOVER data to advance your research
On December 9, 2025, the RECOVER Initiative hosted the first webinar in a two-part series to help researchers use data from the initiative’s observational studies to advance Long COVID research. This webinar is part of the RECOVER Research Review (R3) Seminar Series, which brings the scientific community together to accelerate diagnosing, preventing, and treating Long COVID.
R3 Seminar Recap
RECOVER Research Update: December 2025
Researchers across the initiative continue to refine methods to accurately identify Long COVID, learn more about potential treatments, and understand how the condition impacts different groups of people.
Research Update
RECOVER-ENERGIZE clinical trials achieve early enrollment: How collaboration and communication drove success
A network of 42 RECOVER sites across the US worked to reach out to potential study participants, communicate with the trial team, and reach the trials’ enrollment goal 2 months ahead of schedule.
Feature
Over 1.4 million biosamples available in RECOVER’s biorepository to support Long COVID research
Biostatisticians and clinicians work together to help funded study teams access resources stored in RECOVER’s biorepository, a unique collection of biosamples from almost 30,000 adults and children.
Feature
RECOVER-TLC invites public comments on upcoming clinical trials
Feedback from patients, caregivers, and others will help shape studies testing the safety and effectiveness of potential Long COVID treatments.
Announcement
Study reveals insights into Long COVID trajectories in adults
A study from Mass General Brigham followed 3,659 adults to identify eight different paths that Long COVID can take, based on symptoms and length of illness. The results will inform future studies and possible treatments for Long COVID.
News Release